insights_auto
Why is PTX down 3.03%?
Dive Deeperchevron_right
PTX:ASX
Prescient Therapeutics Ltd
A$0.064
arrow_downward
-3.03%(-0.0020) 1D
Oct 12, 12:10:47 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PTX...
Open
A$0.06
High
A$0.06
Low
A$0.06
Mkt. cap
69.02M
Avg. vol.
1.04M
Volume
30.43K
52-wk high
A$0.12
52-wk low
A$0.04
EPS
-A$0.01
Shares outstanding
1.14B
No. of employees
3
Open
A$0.06
High
A$0.06
Low
A$0.06
Mkt. cap
69.02M
Avg. vol.
1.04M
Volume
30.43K
52-wk high
A$0.12
52-wk low
A$0.04
EPS
-A$0.01
Shares outstanding
1.14B
No. of employees
3
News stories
From web sources and news partners
Stock Titan
·
1 hour ago
A humanoid robot for developers and schools is among four launches planned for Oct. 14.
StreetInsider
·
12 minutes ago
XRP News Today: Nasdaq Exposure Could Transform XRP as Remittix Targets Everyday Payment Adoption
Stock Titan
·
50 minutes ago
In fiscal 2026, customers bought 466 vehicle energy storage systems from Scage.
Barchart.com
·
3 hours ago
The S&P 500 Is Near Record Highs. So Why Does Your Portfolio Feel Like a Bear Market?
Profile
Prescient Therapeutics is a clinical-stage oncology company developing targeted therapies. Prescient's technologies emanate from prestigious world class centres including Yale, Penn, Oxford and Moffitt. Wikipedia
About Prescient Therapeutics Ltd
CEOSteven Yatomi-Clarke
Employees3
FoundedMay 22, 1986
Headquarters-
SectorBiotechnology
Websiteptxtherapeutics.com